— Why it moved
Why PMI Stock More Than Doubled Today — June 2, 2026
SynCardia's parent said its next-gen Emperor artificial heart passed preclinical implant studies, and 826 million shares chased a 17-cent stock that had already lost 99% from its high.
What moved PMI stock
Picard Medical is the parent of artificial-heart maker SynCardia. It announced successful next-generation preclinical implant studies for its Emperor Total Artificial Heart. Genuine news, but preclinical is the operative word.
The mechanics
PMI came into the day at $0.17, almost 99% below its 52-week high. A stock that broken with a 26M float doesn't need much of a push, and the headline pulled in 826M shares of volume, the float turning over more than 30 times in one session.
PMI by the numbers
The alert window
The Stock Pulse alert came at 7:25 AM at $0.356. The stock ground higher for almost two hours and topped at $0.4131 at 9:14 AM, 109 minutes after the alert, up 16%. A real-time reader had a slow premarket grind for a modest gain, and it ended sixteen minutes before the opening bell.
How PMI's move ended
Sellers took over right after the bell and it closed at $0.2746, 23% under the alert. Peak to close was a 34% drawdown, and the premarket buyers who held all day round-tripped. Preclinical implants are years from approval, and this is a company doing about $1M a quarter in revenue. When a 99%-broken chart doubles premarket on early-stage science, the open is the event to watch; the crowd that bought the grind sells the bell.